Key result
Japanese patients with a high DAPT score demonstrated a low 3-year cumulative incidence of ischemic events following successful drug-eluting stent implantation.
Answers are grounded in this paper and cite their sources.
This editorial discusses the first validation of the DAPT score in East Asian patients, confirming its robustness while highlighting the overall lower ischemic risk in Japanese patients compared to Western cohorts.
Article, see p 551 I n this issue of Circulation, Yoshikawa et al 1 provide important information about the validity of the DAPT score (Dual Antiplatelet Therapy) 2 for the prediction of future ischemic events in Japanese patients after implantation of drug-eluting stents.The original DAPT trial 3 did not include patients from East Asian countries.Thus, the work by Yoshikawa et al is the first validation of the DAPT score in East Asian patients.In the present study, patients with multiple risk factors, including diabetes mellitus, cigarette smoking, and history of heart failure, in addition to local thrombogenic conditions related to smaller stent diameter or vein graft stenting, were at high risk of ischemic events.The data provided by Yoshikawa et al confirmed the robustness of the DAPT score even in patients outside the DAPT trial.Lower ischemic risks have been seen in Japanese patients compared with patients from other countries in previous registries of stable outpatients with or at risk for atherothrombotic complications, even after adjustment for known risk factors.4 Yoshikawa et al confirmed overall low ischemic risk in their study population, who were stable during the first 13 months after successful drug-eluting stent implantation, without myocardial infarction (MI), stent thrombosis, or serious bleeding.1 Despite the use of the same definition of the primary ischemic end point (the composite of MI and definite/probable stent thrombosis 5 ), the cumulative 3-year incidence of ischemic events of 1.5% in patients with a high DAPT score shown in the Yoshikawa et al registry was even lower than the event rate of 1.7% seen in 18 months of follow-up of patients with low DAPT scores with continuous dual antiplatelet therapy in the original DAPT trial. 2 The limitations of the indirect comparison between the Yoshikawa et al registry and the DAPT study should be noted.First, MI, an important component of the primary ischemic end point, was defined differently.In the DAPT trial, the use of troponin was permitted in addition to the creatine kinase-MB isoenzyme, 3 whereas only creatine kinase-MB was used in a part of the Yoshikawa et al combined registry.Although the clinical end points were adjudicated by independent event committees in both studies, the less sensitive definition of MI might have contributed to the apparently low number of ischemic events in this registry.Second, ≈40% of patients recruited in the DAPT study had presented with an acute coronary syndrome at the time of percutaneous coronary intervention (PCI), 3 whereas >70% of patients in the Yoshikawa et al registry presented with stable angina. 1 Third, within the clinical presentation of patients with acute coronary syndrome, non-ST-segment-elevation MI was predominant in the DAPT trial, 3 whereas the Yoshikawa et al registry did not provide information on the classification of MI.Previous comparative registries of acute coronary syndrome recruiting patients from Japan 6,7 suggest that ST-segment-elevation MI is predominant in Japanese patients.Another analysis 7 has suggested that the long-term prognosis of non-ST-segment-elevation MI Validation of DAPT Score (Dual Antiplatelet Therapy)
No takes yet. Share an insight, caveat, or question.
Yabushita et al. (2018) conducted an editorial in Post-drug-eluting stent implantation. High DAPT score was evaluated on Composite of MI and definite/probable stent thrombosis. Japanese patients with a high DAPT score demonstrated a low 3-year cumulative incidence of ischemic events following successful drug-eluting stent implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: